Abstract:Abstract More and more studies show that the efficacy of many kinds of anti-cancer therapies, including chemotherapy, radiotherapy, targeting therapy and even immunotherapy, require host activated anti-tumor immune responses. However, the regulation mechanisms of anti-tumor immunity are not fully understood yet. Here, we show that a transcription regulator, Inhibitor of DNA binding 2 (ID2), could positively regulate the anti-tumor immunity. E and ID proteins are both HLH proteins and play important roles in the development of various immune cells. E proteins can form homodimers or heterodimers with HLH proteins and function as transcription activators or repressors, while ID proteins can prevent E proteins from binding to DNA. With a T cell specific ID2 knockout mice (Cd4-cre; Id2 fl/fl), we found that the anti-cancer efficacy of oxaliplatin and anti-PD-L1 treatment for subcutaneous transplant tumor model required ID2 expression in T cells. Further experiments showed that these anti-cancer therapies could induce IFNg production in wild type mice, but failed in ID2 deficient mice. Moreover, the tumor infiltrating cytotoxic CD8+ T cells, but not CD4+ T cells, were dramatically reduced in ID2 deficient mice compared their littermate controls. Our hypothesis is that post the anti-cancer therapy, ID2 could be upregulated and promote CD8+ T cell activation and migration into the tumor sites, then mediate the anti-tumor effect. Since E proteins are main targets of ID2, small molecules targeting E protein may be new choices for boosting anti-tumor immunity to enhance the efficacy of anti-cancer therapies. Supported by grants from Tsinghua University and The Recruitment Program for Young Professionals (to X.G.).

Etoposide-induced Protein 2.4 Regulates The Development and IFN-γ Production of iNKT Cells

Etoposide induced Protein 2.4 Regulates The Development and IFN-gamma Production of iNKT Cells

Transcription factor E2F1 suppresses dendritic cell maturation.

Osteopontin Regulates Development And Function Of Invariant Natural Killer T Cells

Ets1 Promotes the Differentiation of Post-Selected iNKT Cells through Regulation of the Expression of Vα14Jα18 T Cell Receptor and PLZF

Etoposide-induced protein 2.4 functions as a regulator of the calcium ATPase and protects pancreatic β-cell survival

Diacylglycerol Kinase Zeta Positively Controls the Development of Inkt-17 Cells.

Essential Role of NPAT in Regulating T Cell Development and Function

Regulation of Activated Cd4(+) T Cells by Nk Cells Via the Qa-1-Nkg2a Inhibitory Pathway

Id2-Dependent Anti-Tumor Immunity Promotes Anti-Cancer Therapies Effects

The P53-Induced Gene Ei24 is an Essential Component of the Basal Autophagy Pathway

Eed-dependent histone modification orchestrates the iNKT cell developmental program alleviating liver injury

Signal Control of Inkt Development and Effector Lineage Differentiation (P1208)

PDCD5 regulates iNKT cell terminal maturation and iNKT1 fate decision

Id3 and Id2 Act As a Dual Safety Mechanism in Regulating the Development and Population Size of Innate-Like Γδ T Cells.

iNKT Cells Suppress Pathogenic NK1.1+CD8+ T Cells in DSS-Induced Colitis

Opposing Effect of IFNγ and IFNα on Expression of NKG2 Receptors: Negative Regulation of IFNγ on NK Cells

Optineurin modulates the maturation of dendritic cells to regulate autoimmunity through JAK2-STAT3 signaling

E protein control of NKγδT cell development through both generation and function of the stereotypic Vγ1Vδ6.3 TCR

17β-Estradiol Suppresses Cytotoxicity and Proliferative Capacity of Murine Splenic NK1.1 + Cells

Regulatory NK1.1−CD4+NKG2D+ subset induced by NKG2DL+ cells promotes tumor evasion in mice